Table of Contents Maintaining optimal health and wellness can be challenging
Add-on to 1-3 oral anti-hyperglycemic agents (metformin, sulfonylurea, or SGLT-2 inhibitor) SURPASS-4 (NCT03730662) was a 104-week open-label trial (52-week primary endpoint) that randomized 2002 adult patients with type 2 diabetes mellitus with increased cardiovascular risk to subcutaneous MOUNJARO 5 mg, MOUNJARO 10 mg, MOUNJARO 15 mg once weekly, or insulin glargine 100 units/mL once daily (1:1:1:3 ratio) on a background of metformin (95%) and/or sulfonylureas (54%) and/or SGLT2 inhibitors (25%)
Vitamin B12 plays a key role in many bodily functions, like making red blood cells and supporting the nervous system
This rapid clearance contrasts sharply with its prolonged biological effects, which is the basis of the Gene Expression Paradox
Alfadhel M, Almuntashri M, Jadah RH, Bashiri FA, Al Rifai M, Al Shalaan H, et al